aMoon Fund
Edit

aMoon Fund

https://www.amoon.fund/
Last activity: 28.12.2024
Active
Invests in categories: HealthTechPlatformMedtechCareDataDiagnosticsDrugTechnologyProductAnalytics
aMoon is a global HealthTech and Life Sciences investment fund based in Israel. As Israel’s largest HealthTech fund, with $1.1 billion AUM, we partner with outstanding entrepreneurs who harness groundbreaking science and technology to transform healthcare.

Together with our portfolio companies, we work tirelessly to advance solutions that will help people live healthier, better lives.

We harness our unique team of over 50 scientists, physicians and entrepreneurs and our global network of investors and industry leaders to build bridges between our portfolio companies and global tech, finance and medical research hubs to help entrepreneurs turn their vision into reality.

Through our Velocity Fund we invest in companies pursuing disruptive, cutting-edge technologies as early as venture formation through Series A. Our Growth Fund invests in later-stage companies that are either generating revenue in growth rounds, pre-IPO rounds or in pivotal clinical trials.
News
148
Portfolio
48
Persons
11
Mentions
35
Location: Israel, Center District, Raanana
Employees: 11-50
Founded date: 2016
Investment Type: Venture Capital
Investment Stage: Series A; Series B; Series D; Pre-IPO

Portfolio 48

DateNameWebsiteTotal RaisedLocation
28.12.2024Breeoot Cl...breeoot.com--
28.12.2024Air Doctorair-dr.com$47.8MIsrael
28.12.2024Hopscotch ...hellohopscotch.com-United Sta...
10.01.2024Connie Hea...conniehealth.com$13MUnited Sta...
14.08.2023Better Lif...betterlifepartners.com$26.5MUnited Sta...
01.08.2023Akoya Bios...akoyabio.com$50MUnited Sta...
23.06.2022Lyfegenlyfegen.com$16.56MSwitzerlan...
02.06.2022Ultima Gen...ultimagenomics.com$600MUnited Sta...
13.04.2022GraphiteRxgraphiterx.com-United Sta...
13.04.2022Omada Heal...omadahealth.com$584.5MUnited Sta...
Show more

Persons 11

DateFirst NameLast NameTitleLinkedInLocation
-RebeccaPeretzPersonal A...linkedin.c...-
-TamarFarfel-Bec...Principallinkedin.c...-
-YonatanShayAnalyst In...linkedin.c...-
-OsnatHakimi, Ph...Associatelinkedin.c...-
-TomerBerkovitz,...Managing P...linkedin.c...-
-ToddSone, MBAGeneral Pa...linkedin.c...-
-GurRoshwalb, ...Partnerlinkedin.c...-
-AdamKotzenAssociatelinkedin.c...-
-AlonAltschuler...Principallinkedin.c...-
-YairSchindel, ...Co-Founder...linkedin.c...-
Show more

News 148

DateTitleDescription
29.04.2024Seizing the HealthTech opportunity: Early-stage innovation takes center stage-
04.03.2024Qumra’s Top 11: The Israeli startups to watch out for in 2024-
13.02.2024Omada GLP-1 program to prioritize muscle mass restoration through expanded care track-
09.01.2024Quest Diagnostics and Ultima Collaborate to Scale Ultima’s Technology in Fast-Growing Minimal Residual Disease and Whole Genome Sequencing-
08.01.2024Amazon Health Launches New Initiative To Address Chronic Conditions-
20.12.2023A new test could save arthritis patients time, money and pain. But will it be used?-
14.12.2023Teva Pharma To Receive Exclusive Rights To Develop, Manufacture And Commercialize BD9-
30.11.2023Mapping mental health innovation in Israel-
29.11.20232023 Fierce Life Sciences Innovation Awards Winners-
28.11.2023The 6 next big things in healthtech for 2023-
Show more

Mentions in press and media 35

DateTitleDescription
13.12.2024TX Ventures leads CHF 5 million round at Lyfegen The healthcare industry faces increasing challenges with rising drug costs and the complexity of managing growing volumes of rebate agreements. For payers and pharmaceutical companies, manual processes often lead to inefficiencies, complia...
06.11.2024PrognomiQ's $34 Million Boost: A New Dawn for Lung Cancer DetectionIn the realm of healthcare, innovation is the lifeblood that fuels progress. PrognomiQ, a rising star in the diagnostics industry, has just secured a significant $34 million in Series D funding. This financial windfall, led by Seer, Inc., m...
05.11.2024PrognomiQ Raises $34M to Advance Multi-Omics Early Detection Test for Lung CancerWhat You Should Know: – PrognomiQ, a healthcare company pioneering multi-omics approaches to disease detection, has secured $34M in Series D funding led by Seer, Inc., with participation from a new strategic investor and existing investors ...
06.09.2023Ibex Medical Analytics Raises $55M to Drive AI for Cancer Diagnosis Adoption GloballyWhat You Should Know: – Ibex Medical Analytics (Ibex), a provider of AI-powered cancer diagnostics raises $55M in Series C financing round led by 83North. – The round also included participation from Sienna Venture Capital and existing inve...
01.09.2023Better Life Partners Raises $26.5M to Expand Virtual SUD PlatformWhat You Should Know: – Better Life Partners, a virtual and in-person, community-embedded, whole-health solution for individuals and populations with substance use disorders (SUD) raises $26.5M in Series B funding round. – The round is co-l...
30.11.2022Nectin Therapeutics Raises $25M for Immuno-Oncology TherapiesWhat You Should Know: The company also announced dosing of the first patient in its Phase 1 clinical trial of NTX1088, Nectin’s first-in-class PVR blocker, in cancer patients with locally advanced and metastatic solid tumors. NTX1088 is a f...
23.09.2022Lyfegen raises $8M for its value-based drug contracting platformSpecialty medication prices in the U.S. are out of control. Despite making up about 2% of overall prescription volume, specialty drugs accounted for 53% of total annual pharmacy spending last year — up from 27% in 2010 — caused in part by g...
21.09.2022Lyfegen secures $8 million to drive down drug costs
20.09.2022Lyfegen Raises $8M for Value-Based Contracting for High-Cost DrugsWhat You Should Know: Currently, less than 2% of the health insurance population requiring specialty drugs is responsible for 51% of drug spending. The cost of specialty drugs in the US is spiraling out of control, increasing 12% from 2020 ...
05.04.2022Eleos Closes $20M to Unlock CareOps Automation for Behavioral HealthWhat You Should Know: – Eleos Health has announced a $20 million Series A round, co-led by F-Prime Capital and Eight Roads Ventures, bringing their total raise to $28 million. – Eleos Health is a behavioral health application for voice AI, ...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In